UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$475M |
| 2 |
Vanguard Real Estate ETF
VNQ
|
+$349M |
| 3 |
iShares MSCI ACWI ETF
ACWI
|
+$346M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$261M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.91B |
| 2 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$1.28B |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.17B |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$1.11B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$968M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.93% |
| 2 | Financials | 6.61% |
| 3 | Consumer Discretionary | 6.23% |
| 4 | Healthcare | 5.77% |
| 5 | Communication Services | 4.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Burlington
BURL
$23.2B
| $11.5M | ﹤0.01% |
43,949
+11,224
| +34% | +$2.5M |
|
1752
Lamb Weston
LW
$7.19B
| $11.4M | ﹤0.01% |
145,055
-20,497
| -12% | -$1.49M |
|
1753
BioMarin Pharmaceuticals
BMRN
$12.4B
| $11.4M | ﹤0.01% |
130,088
+45,648
| +54% | +$3.62M |
|
1754
Invesco S&P 500 Equal Weight Consumer Staples ETF
RSPS
$257M
| $11.4M | ﹤0.01% |
376,525
-18,120
| -5% | -$535K |
|
1755
PVH
PVH
$4.04B
| $11.4M | ﹤0.01% |
121,069
+40,873
| +51% | +$3.11M |
|
1756
CALL
3M
MMM
$94.3B
| $11.4M | ﹤0.01% |
77,740
+47,840
| +160% | +$6.79M |
|
1757
Factset
FDS
$10.2B
| $11.3M | ﹤0.01% |
33,897
-14,386
| -30% | -$4.75M |
|
1758
HEICO Corp Class A
HEI.A
$37.2B
| $11.3M | ﹤0.01% |
96,285
+1,736
| +2% | +$189K |
|
|
XLRN
1759
DELISTED
Acceleron Pharma
XLRN
| $11.2M | ﹤0.01% |
87,787
+2,847
| +3% | +$334K |
|
1760
ProShares Short Russell2000
RWM
$129M
| $11.2M | ﹤0.01% |
441,751
-21,660
| -5% | -$628K |
|
|
PSTH
1761
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
| $11.2M | ﹤0.01% |
404,259
+137,650
| +52% | +$3.32M |
|
1762
Nice
NICE
$5.97B
| $11.2M | ﹤0.01% |
39,458
-6,424
| -14% | -$1.56M |
|
1763
Royalty Pharma
RPRX
$25.3B
| $11.2M | ﹤0.01% |
223,086
+169,536
| +317% | +$7.19M |
|
|
NVTA
1764
DELISTED
Invitae Corporation
NVTA
| $11.2M | ﹤0.01% |
266,887
+77,107
| +41% | +$3.68M |
|
1765
PUT
Fortinet
FTNT
$117B
| $11.1M | ﹤0.01% |
+375,000
| New | +$9.48M |
|
1766
Columbia Emerging Markets Consumer ETF
ECON
$337M
| $11.1M | ﹤0.01% |
395,153
+16,532
| +4% | +$442K |
|
|
HIX
1767
Western Asset High Income Fund II
HIX
$355M
| $11.1M | ﹤0.01% |
1,616,053
-265,643
| -14% | -$1.79M |
|
1768
Moelis & Co
MC
$4.94B
| $11.1M | ﹤0.01% |
237,356
+8,994
| +4% | +$362K |
|
|
UFS
1769
PUT
DELISTED
DOMTAR CORPORATION (New)
UFS
| $11.1M | ﹤0.01% |
350,000
| – | – |
|
1770
CALL
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$228M
| $11.1M | ﹤0.01% |
416
+245
| +143% | +$8.93M |
|
1771
Dick's Sporting Goods
DKS
$18.7B
| $11.1M | ﹤0.01% |
196,830
-28,297
| -13% | -$1.61M |
|
1772
CALL
ServiceNow
NOW
$129B
| $11.1M | ﹤0.01% |
100,500
| – | – |
|
|
Y
1773
DELISTED
Alleghany Corp
Y
| $11M | ﹤0.01% |
18,259
+210
| +1% | +$123K |
|
|
CYBR
1774
DELISTED
CyberArk
CYBR
| $11M | ﹤0.01% |
68,203
-10,246
| -13% | -$1.19M |
|
|
TRIL
1775
DELISTED
Trillium Therapeutics Inc.
TRIL
| $11M | ﹤0.01% |
744,630
+743,813
| +91,042% | +$10.7M |
|
Similar funds
UBS Group's Q4 2020 Portfolio in Review
As of Q4 2020, UBS Group held 9,236 positions worth $296B, up 11% from $265B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q4 2020 filing shows 1,125 new, 3,976 increased, 2,989 reduced and 738 closed positions. Its largest new stake was Vontier: 502,899 shares worth $16.8M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.91B.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.
- UBS Group's largest Q4 2020 buy was Vontier: 502,899 shares worth $16.8M.
- UBS Group added most to UBS Group in Q4 2020, an estimated $475M increase.
- UBS Group's biggest Q4 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.91B.
- UBS Group fully exited Delphi Technologies PLC Ordinary Shares in Q4 2020, selling an estimated $96.7M.
- UBS Group's ten largest holdings make up 14% of its $296B portfolio in Q4 2020.
- UBS Group opened 1,125 new positions and closed 738 in Q4 2020.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $296B.
Based on UBS Group's 13F filing for Q4 2020, filed 11 Feb 2021.